Mingyue Yang
No. 215, West Heping Road
Shijiazhuang, China
Shijiazhuang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Mesalazine enteric-coated tablets combined with retention enema for symptom alleviation in mild to moderate E2-type active ulcerative colitis: A retrospective comparative cohort study.
Journal: Pakistan journal of pharmaceutical sciences
Published: September 08, 2026
Astragaloside IV ameliorates DSS-induced intestinal epithelial barrier dysfunction associated with modulation of tight junction proteins and MLCK/p-MLC and MyD88/TRAF6 signaling pathways.
Journal: Frontiers in pharmacology
Published: December 31, 2025
Association of neutrophil-to-albumin ratio with all-cause and cardiovascular mortality in community-dwelling individuals with chronic kidney disease: evidence from the NHANES 1999-2018.
Journal: BMC cardiovascular disorders
Published: February 18, 2025
Tumor necrosis factor ligand-related molecule 1A affects the intestinal mucosal barrier function by promoting Th9/interleukin-9 expression.
Journal: The Journal of international medical research
Published: June 23, 2020
TL1A primed dendritic cells activation exacerbated chronic murine colitis.
Journal: Life sciences
Published: April 06, 2020
Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis.
Journal: Digestive diseases and sciences
Published: November 21, 2018
Tumor Necrosis Factor Ligand-Related Molecule 1A Regulates the Occurrence of Colitis-Associated Colorectal Cancer.
Journal: Digestive diseases and sciences
Published: March 07, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026